Skip Navigation



Hum. Reprod. Advance Access published online on January 18, 2007

Human Reproduction, doi:10.1093/humrep/del517
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow All Versions of this Article:
22/5/1335    most recent
del517v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Liberty, G.
Right arrow Articles by Margalioth, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liberty, G.
Right arrow Articles by Margalioth, E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Lidocaine–Prilocaine (EMLA) cream as analgesia for hysterosalpingography: a prospective, randomized, controlled, double blinded study

G. Liberty1,3, M. Gal1, T. Halevy-Shalem1, R. Michaelson-Cohen1, N. Galoyan1, J. Hyman1, T. Eldar-Geva1, E. Vatashsky2 and E. Margalioth1

1 Department of Obstetrics and Gynecology 2 Department of Anesthesia, Shaare Zedek Medical Center, Jerusalem, Faculty of Health Science, Ben-Gurion University of the Negev, Beer Sheba, Israel

3 To whom correspondence should be addressed at: Department of Obstetrics and Gynecology, Shaare Zedek Medical Center, Jerusalem. E-mail: liberg{at}013.net.il

BACKGROUND: The aim of our study is to evaluate the efficacy of applying lidocaine 25 mg–prilocaine-25 mg/G cream (EMLA 5%) on the uterine cervix for pain relief when performing hysterosalpingography (HSG).

METHODS: Eighty-two patients undergoing HSG as part of infertility evaluation were randomized into groups receiving EMLA (42) or placebo cream (40) in a double-blinded prospective study from which four women were later excluded. The cream was applied to the uterine cervix by means of a cervical cup 30 min before the HSG. Pain perception related to the HSG procedure was scored by visual analogue scale (VAS) at five predefined steps: after speculum application, after cervical instrumentation of the tenaculum and cannula, at the end of uterine filling, at completion of tubal spillage, and immediately following instrument removal. In addition, the patients were asked to retrospectively rate the pain during the entire procedure in a telephone interview the following day.

RESULTS: Cervical instrumentation was found to be the most painful step of HSG (P < 0.001). When comparing the VAS pain scores, cervical instrumentation in the EMLA-treated patients was associated with significantly less pain than the control group: 3.3 ± 2.9 versus 4.9 ± 2.7, respectively (P = 0.02).

CONCLUSION: Topical application of EMLA 5% cream on the uterine cervix before performing HSG significantly reduced the pain during this procedure.

Key words: hysterosalpingography/local anaesthetic/pain relief/uterine cervix/visual analogue scale


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
S.F.P.J. Coppus, H.R. Verhoeve, B.C. Opmeer, J.W. van der Steeg, P. Steures, M.J.C. Eijkemans, P.G.A. Hompes, P.M.M. Bossuyt, F. van der Veen, and B.W.J. Mol
Identifying subfertile ovulatory women for timely tubal patency testing: a clinical decision rule based on medical history
Hum. Reprod., October 1, 2007; 22(10): 2685 - 2692.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.